Milam 7.5MG


Milam 7.5MG


Stock Status:

In Stock

  • *Upload Prescription

    • (max file size 80 MB)



Midazolam is used to treat insomnia for a short period of time.

Before surgical or diagnostic operations, sedation is used as a premedication.


Pharmaceutical Name

Eskayef Pharmaceuticals Ltd.



The inhibitory neurotransmitter gamma-aminobutyric acid (GABA), which is one of the primary inhibitory neurotransmitters in the central nervous system, mediates the effects of benzodiazepines like midazolam. Benzodiazepines enhance GABA activity, causing sedation, relaxation of skeletal muscles, and induction of sleep, anesthesia, and forgetfulness. Benzodiazepines bind to the benzodiazepine site on GABA-A receptors, increasing the frequency of chloride channel opening and therefore potentiating the effects of GABA. These receptors have been found in a variety of bodily tissues, including the heart and skeletal muscle, although they appear to be primarily found in the central nervous system.


Dosage & Administration

Oral dosage:

  • For adults: 7.5-15 mg daily.
  • In elderly and debilitated patients: The recommended dose is 7.5 mg.
  • In premedication: 15 mg of Midazolam should be given 30-60 minutes before the procedure.

Intravenous administration:

  • Endoscopic or Cardiovascular Procedures: In healthy adults, the initial dose is approximately 2.5 mg. In cases of severe illness and in elderly patients, the initial dose must be reduced to 1 to 1.5 mg.
  • Induction of Anesthesia: The dose is 10-15 mg.

Intramuscular administration:

  • Adult: 0.07-0.1 mg/kg body weight. The usual dose is about 5 mg.
  • Children: 0.15-0.20 mg/kg
  • Elderly and debilitated patients: 0.025-0.05 mg/kg

Rectal administration in children:

  • For preoperative sedation: Rectal administration of the ampoule solution (0.35-0.45 mg/kg) 20-30 min. before induction of general anesthesia.



Neuroleptics, tranquillizers, antidepressants, sleep-inducing medicines, analgesics, anaesthetics, antipsychotics, anxiolytics, antiepileptic drugs, and sedative antihistamines can all be enhanced by midazolam.



Patients with severe respiratory insufficiency, severe hepatic insufficiency, myasthenia gravis, sleep apnea syndrome, or known hypersensitivity to benzodiazepines or any component of the medication should not be administered midazolam.


Side Effect

Drowsiness throughout the day, disorientation, tiredness, headache, and muscular weakness may occur at the start of treatment, although these side effects generally fade away with repeated dosing. Changes in vital signs have been seen following parenteral (IV or IM) injection of Midazolam, including respiratory depression, apnea, blood pressure alterations, and pulse rate variations.


Pregnancy & Lactation

Unless there is no other option, midazolam should be avoided during pregnancy. Because midazolam travels into breast milk, it should not be given to nursing women.


Precautions & Warnings

Midazolam IV should be administered very slowly.


Therapeutic Class

Benzodiazepine hypnotics, Benzodiazepine sedatives


Storage Conditions

Store in a cool, dry area away from light and moisture. Keep out of children’s reach.